CU20090206A7 - Solución novedosa no-acuosa tópica de diclofenaco y proceso para su preparación - Google Patents

Solución novedosa no-acuosa tópica de diclofenaco y proceso para su preparación

Info

Publication number
CU20090206A7
CU20090206A7 CU20090206A CU20090206A CU20090206A7 CU 20090206 A7 CU20090206 A7 CU 20090206A7 CU 20090206 A CU20090206 A CU 20090206A CU 20090206 A CU20090206 A CU 20090206A CU 20090206 A7 CU20090206 A7 CU 20090206A7
Authority
CU
Cuba
Prior art keywords
diclofenaco
novedous
preparation
watery solution
solution typical
Prior art date
Application number
CU20090206A
Other languages
English (en)
Other versions
CU23999B1 (es
Inventor
R Patel Ketan
Original Assignee
Troikaa Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Troikaa Pharmaceuticals Ltd filed Critical Troikaa Pharmaceuticals Ltd
Publication of CU20090206A7 publication Critical patent/CU20090206A7/es
Publication of CU23999B1 publication Critical patent/CU23999B1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se describe una composición en solución novedosa no-acuosa tópica de sal de diclofenaco farmacéuticamente aceptable. La composición en solución no-acuosa tópica comprende una cantidad terapéuticamente efectiva de sal de diclofenaco farmacéuticamente aceptable, solubilizante, un potenciador de la penetración y solvente, y opcionalmente, un humectante, un revulsivo o irritante local, un potenciador adicional de la penetración y anti-oxidantes, así como su proceso de preparación.
CU2009000206A 2007-06-08 2009-12-04 Solución no-acuosa tópica de diclofenaco y proceso para su preparación CU23999B1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1092MU2007 2007-06-08
PCT/IN2008/000363 WO2009047785A2 (en) 2007-06-08 2008-06-09 A non-aqueous topical solution of diclofenac and process for preparing the same

Publications (2)

Publication Number Publication Date
CU20090206A7 true CU20090206A7 (es) 2011-09-21
CU23999B1 CU23999B1 (es) 2014-06-27

Family

ID=40524886

Family Applications (1)

Application Number Title Priority Date Filing Date
CU2009000206A CU23999B1 (es) 2007-06-08 2009-12-04 Solución no-acuosa tópica de diclofenaco y proceso para su preparación

Country Status (23)

Country Link
US (1) US10702469B2 (es)
EP (1) EP2211837B1 (es)
JP (2) JP5535066B2 (es)
KR (1) KR101517494B1 (es)
CN (1) CN101790370B (es)
AP (1) AP3643A (es)
AU (1) AU2008309170B2 (es)
BR (1) BRPI0811956A8 (es)
CA (1) CA2697458C (es)
CO (1) CO6270203A2 (es)
CU (1) CU23999B1 (es)
DK (1) DK2211837T3 (es)
EA (1) EA018119B1 (es)
ES (1) ES2445443T3 (es)
HK (1) HK1147066A1 (es)
IL (1) IL202009A (es)
MX (1) MX2009013352A (es)
MY (1) MY151437A (es)
PL (1) PL2211837T3 (es)
PT (1) PT2211837E (es)
UA (1) UA97529C2 (es)
WO (1) WO2009047785A2 (es)
ZA (1) ZA200908705B (es)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100099766A1 (en) * 2008-10-16 2010-04-22 Novartis Ag Topical NSAID compositions having sensate component
EP2416816B1 (en) * 2009-04-10 2014-10-15 Spiracur Inc. Methods and devices for applying closed incision negative pressure wound therapy
US11224659B2 (en) 2010-10-29 2022-01-18 Infirst Healthcare Limited Solid solution compositions and use in severe pain
US9308213B2 (en) 2010-10-29 2016-04-12 Infirst Healthcare Limited Solid solution compositions and use in chronic inflammation
US9744132B2 (en) 2010-10-29 2017-08-29 Infirst Healthcare Limited Solid solution compositions and use in chronic inflammation
US11202831B2 (en) 2010-10-29 2021-12-21 Infirst Healthcare Limited Solid solution compositions and use in cardiovascular disease
US9504664B2 (en) 2010-10-29 2016-11-29 Infirst Healthcare Limited Compositions and methods for treating severe pain
US8895537B2 (en) 2010-10-29 2014-11-25 Infirst Healthcare Ltd. Compositions and methods for treating cardiovascular diseases
US10695431B2 (en) 2010-10-29 2020-06-30 Infirst Healthcare Limited Solid solution compositions and use in cardiovascular disease
US10695432B2 (en) 2010-10-29 2020-06-30 Infirst Healthcare Limited Solid solution compositions and use in severe pain
US11730709B2 (en) 2010-10-29 2023-08-22 Infirst Healthcare Limited Compositions and methods for treating severe pain
US9271950B2 (en) 2010-10-29 2016-03-01 Infirst Healthcare Limited Compositions for treating chronic inflammation and inflammatory diseases
US9737500B2 (en) 2010-10-29 2017-08-22 Infirst Healthcare Limited Compositions and methods for treating severe pain
ITMI20121205A1 (it) 2012-07-11 2014-01-12 Glycores 2000 Srl Composizione con attivita' antinfiammatoria ed analgesica da somministrare per uso esterno mediante vaporizzazione
JP2014152172A (ja) * 2013-02-08 2014-08-25 Daiya Seiyaku Kk 清涼感付与外用組成物、清涼感付与貼付剤、清涼感付与方法、清涼感付与外用組成物の製造方法、及び、清涼感付与貼付剤の製造方法
BR112015020707B1 (pt) * 2013-02-27 2022-09-13 Laurie Robert Batt Composição transdérmica anidra e método de fabricação da mesma
JP6738120B2 (ja) * 2013-03-29 2020-08-12 小林製薬株式会社 外用医薬組成物
JP6599083B2 (ja) * 2014-03-30 2019-10-30 小林製薬株式会社 外用医薬組成物
JP6580305B2 (ja) * 2014-03-30 2019-09-25 小林製薬株式会社 外用医薬組成物
JP6580306B2 (ja) * 2014-03-30 2019-09-25 小林製薬株式会社 外用医薬組成物
KR20190003535A (ko) * 2016-03-31 2019-01-09 스마테크 토피칼, 인코포레이티드 전달 시스템
JP7250689B2 (ja) * 2017-03-07 2023-04-03 イッサム・リサーチ・ディベロップメント・カンパニー・オブ・ザ・ヘブルー・ユニバーシティ・オブ・エルサレム・リミテッド 活性化合物のための局所送達系
JP2018030893A (ja) * 2017-11-14 2018-03-01 ダイヤ製薬株式会社 清涼感付与外用組成物の製造方法及び清涼感付与貼付剤の製造方法
CN114615974A (zh) * 2019-11-06 2022-06-10 智能科技专题有限公司 环加氧酶抑制剂的局部制剂及其用途
JP2022096997A (ja) * 2020-12-18 2022-06-30 小林製薬株式会社 外用医薬組成物
WO2023180792A1 (en) 2022-03-25 2023-09-28 Glycores 2000 Srl Topical pharmaceutical composition with anti-inflammatory and analgesic activity and uses thereof

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4353896A (en) * 1981-06-08 1982-10-12 Levy Michael A Penetrating topical medicament
US4933184A (en) 1983-12-22 1990-06-12 American Home Products Corp. (Del) Menthol enhancement of transdermal drug delivery
CA1236029A (en) * 1984-05-14 1988-05-03 Edmund Sandborn Pharmaceutical solutions comprising dimethyl sulfoxide
DE3522550A1 (de) 1985-06-24 1987-01-02 Klinge Co Chem Pharm Fab Aufspruehbare pharmazeutische zubereitung fuer die topische anwendung
US5093133A (en) * 1990-01-24 1992-03-03 Mcneil-Ppc, Inc. Method for percutaneous delivery of ibuprofen using hydroalcoholic gel
US5318960A (en) * 1992-06-03 1994-06-07 Frank Toppo System for transdermal delivery of pain relieving substances
US5985860A (en) 1992-06-03 1999-11-16 Toppo; Frank System for transdermal delivery of pain relieving substances
US5665378A (en) * 1994-09-30 1997-09-09 Davis; Roosevelt Transdermal therapeutic formulation
US5654337A (en) * 1995-03-24 1997-08-05 II William Scott Snyder Topical formulation for local delivery of a pharmaceutically active agent
US7833543B2 (en) * 1995-06-07 2010-11-16 Durect Corporation High viscosity liquid controlled delivery system and medical or surgical device
US5968542A (en) * 1995-06-07 1999-10-19 Southern Biosystems, Inc. High viscosity liquid controlled delivery system as a device
WO1997028794A1 (fr) * 1996-02-07 1997-08-14 Tsumura & Co. Solution aqueuse transparente de diclofenac sodique, compositions medicinales, et utilisations
DE19725615A1 (de) 1997-06-17 1998-12-24 Permamed Ag Zur topischen Applikation bestimmte Diclofenac-Lösung
US5976566A (en) * 1997-08-29 1999-11-02 Macrochem Corporation Non-steroidal antiinflammtory drug formulations for topical application to the skin
US6193996B1 (en) * 1998-04-02 2001-02-27 3M Innovative Properties Company Device for the transdermal delivery of diclofenac
CH693625A5 (it) 1999-02-18 2003-11-28 Inpharma Sa Composizioni farmaceutiche contenenti composti ad attività promotrice di assorbimento di principi attivi.
DE60236084D1 (de) * 2001-05-31 2010-06-02 Hisamitsu Pharmaceutical Co Perkutan resorbierbare pflaster
US20070196453A1 (en) * 2004-06-07 2007-08-23 Jie Zhang Two or more non-volatile solvent-containing compositions and methods for dermal delivery of drugs
EP1909772A4 (en) * 2005-08-05 2011-07-13 Nuvo Res Inc TRANSDERMAL DRUG FORMULATION

Also Published As

Publication number Publication date
ZA200908705B (en) 2010-08-25
AP2010005169A0 (en) 2010-02-28
JP5734479B2 (ja) 2015-06-17
US20100120918A1 (en) 2010-05-13
EP2211837B1 (en) 2013-11-13
CA2697458C (en) 2016-02-09
KR101517494B1 (ko) 2015-05-04
AU2008309170A1 (en) 2009-04-16
US10702469B2 (en) 2020-07-07
BRPI0811956A8 (pt) 2015-09-22
IL202009A (en) 2015-10-29
EA018119B1 (ru) 2013-05-30
EA200971099A1 (ru) 2010-06-30
PT2211837E (pt) 2014-02-17
UA97529C2 (ru) 2012-02-27
AP3643A (en) 2016-03-16
EP2211837A2 (en) 2010-08-04
DK2211837T3 (da) 2014-02-10
MY151437A (en) 2014-05-30
JP2014098046A (ja) 2014-05-29
AU2008309170B2 (en) 2013-03-14
JP2010529110A (ja) 2010-08-26
KR20100047840A (ko) 2010-05-10
CO6270203A2 (es) 2011-04-20
CA2697458A1 (en) 2009-04-16
CN101790370A (zh) 2010-07-28
ES2445443T3 (es) 2014-03-03
HK1147066A1 (en) 2011-07-29
PL2211837T3 (pl) 2014-05-30
IL202009A0 (en) 2010-06-16
CU23999B1 (es) 2014-06-27
WO2009047785A3 (en) 2009-07-02
JP5535066B2 (ja) 2014-07-02
BRPI0811956A2 (pt) 2014-11-11
CN101790370B (zh) 2013-06-12
WO2009047785A2 (en) 2009-04-16
WO2009047785A9 (en) 2010-03-11
MX2009013352A (es) 2010-05-21

Similar Documents

Publication Publication Date Title
CU20090206A7 (es) Solución novedosa no-acuosa tópica de diclofenaco y proceso para su preparación
ECSP12011799A (es) Compuestos de espiropiperidina y uso farmacéutico de los mismos
CL2012002880A1 (es) Compuestos derivados de pirrolobenzodiazepinas conjugados, entre otros con anticuerpos; procedimiento de preparación de un conjugado; composicion farmaceutica: procedimiento de tratamiento de cancer; y su uso para proporcionar el compuesto a una localizacion diana que es una poblacion celular proliferativa; articulo de fabricacion
AR068369A1 (es) Sal de xinafoato de n4-[(2,2-difluor-4h-benzo[1,4]oxazin-3-on)-6-il]-5-fluor-n2-[3-(metilaminocarbonilmetilenoxi)-fenil]2,4-pirimidindiamina"
CL2008002076A1 (es) Compuestos derivados de ariloxazoles sustituidos; procedimiento de preparacion de dichos compuestos; composicion farmaceutica que los comprende; y su uso para tratar diabetes, sindrome metabolico, dislipidemias, entre otras enfermedades.
DOP2006000170A (es) Nuevos derivados de espirocromanona
BR112012026767A2 (pt) composto, sal farmaceuticamente aceitável de um composto, composição farmacêutica, método para tratar ou previnir distúrbios, e, uso de um composto ou sal
CL2009000882A1 (es) Un compuesto n-(4-cloro-3-(piridin-2-il)fenil)-4-(2-hidroxi-2-metilpropilsulfonil)-2-metilbenzamida, inhibidor de la via de señalización hedgehog; composición farmacéutica que comprende a dicho compuesto; y su uso para tratar el cancer.
CL2007001759A1 (es) Compuesto metformina r-(+) lipoato; mezcla que comprende metformina y acido r-(+) lipoico; composicion farmaceutica que comprende el compuesto; metodo para preparar el compuesto; kit; y uso para tratar la diabetes.
EA201000814A1 (ru) 5-[(3,3,3-трифтор-2-гидрокси-1-арилпропил)амино]-1h-хинолин-2-оны, способ их получения и их применение в качестве противовоспалительных средств
CL2008001213A1 (es) Uso de compuestos derivados de piridin-4-il-benceno-1,4-diamino sustituidos por alquindol para preparar un medicamento para el tratamiento de un trastorno proliferativo tal como el cancer.
CL2011000544A1 (es) Compuestos derivados de benzamida n sustituida por heterociclo, ligandos de los receptores cannabinoides; composicion farmaceutica; y su uso para tratar el dolor, entre otras enfermedades.
PA8657801A1 (es) Aminalcoholes triciclicos, procedimientos para su preparacion
MY158428A (en) Topical composition for the treatment of actinic keratosis
PE20090512A1 (es) Fenilendiaminas sustituidas como inhibidores de la interaccion entre mdm2 y p53
EA200900090A1 (ru) Бензиламины, способ их получения и их применение в качестве противовоспалительных средств
EA201591499A1 (ru) Замещенные бисфенилбутановые производные фосфоновой кислоты в качестве ингибиторов nep (нейтральная эндопептидаза)
CY1115623T1 (el) Μεθοδος για την συνθεση 7,8-διμεθοξυ-1,3-διϋδρο-2η-3-βενζαζεπιν-2-ονης και εφαρμογη αυτης στη συνθεση της ιβαμπραδινης καθως επισης αλατων προσθηκης αυτης με ενα φαρμακευτικως αποδεκτο οξυ
CR10206A (es) Acidos4-fenil-tiazol-5-carboxilicos amidas de acidos 4-fenil-tiazol-5-carboxilicos como inhibidores de la plk1
EA200700550A1 (ru) Производные алкилидентетрагидронафталина, способ их получения и их применение в качестве противовоспалительных средств
EA200300450A1 (ru) Фармацевтические растворы соединений модафинила
CL2007002919A1 (es) Compuestos derivados de pirido[2,3-b]indol, inhibidores de quinasa; procedimiento de preparacion; composicion farmaceutica; y su uso para tratar cancer, entre otras enfermedades.
EA201100350A1 (ru) Противогрибковые средства
WO2007029036A3 (en) Amino acid derivatives as histone deacetylase (hdac) inhibitors
MX2010005039A (es) Derivados de quinolina y su uso como inhibidores de tirosina quinasa.

Legal Events

Date Code Title Description
FG Grant of patent